(Q53475799)

14 May 2018

review article

1 reference

title

Secondary malignancies following cancer chemotherapy. (English)

1 reference

14 May 2018

1 reference

Boffetta P

1

1 reference

14 May 2018

Kaldor JM

series ordinal

2

1 reference

14 May 2018

publication date

1 January 1994

1 reference

14 May 2018

published in

Acta Oncologica

1 reference

14 May 2018

volume

33

1 reference

14 May 2018

issue

6

1 reference

14 May 2018

page(s)

591-598

1 reference

14 May 2018

Second acute leukemia and other malignancies following treatment for Hodgkin's disease

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121767

Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121767

Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121767

Leukemia following Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121767

Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121767

Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121767

The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121767

The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121767

Leukemia following chemotherapy for ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121767

Second cancer following chemotherapy and radiotherapy. An epidemiological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121767

A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121767

Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121767

Carcinoma of the Urinary Bladder after Treatment with Cyclophosphamide for Non-Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121767

Second malignancies and Hodgkin's disease--the Royal Marsden Hospital experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121767

Lung cancer following Hodgkin's disease: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121767

Incidence of second primary cancer following testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121767

10.3109/02841869409121767

21 January 2018

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018